BREAKING: Dark Horse Consulting Group acquires BioTechLogic, Inc.
WHITE PAPER The High Bar for Gene Therapy CMC How drug developers can step up to meet regulatory expectations for gene therapy chemistry...
Read more
white paper 4 Steps for Managing Biopharmaceutical Projects By Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant, and Julie Spyrison Associate Director,...
BioTechLogic, Inc., is a biopharmaceutical manufacturing and CMC consulting firm with strategic, practical, and hands-on experience that helps clients bring their products to market quickly and successfully by augmenting and optimizing an organization's technical, manufacturing, analytical, and regulatory resources.
Access our on-demand webinar that discusses proactive quality system management that allow pharmaceutical manufacturers to avoid time and resource-intensive filing approval delays, observations, and warning letters. • Deviation, CAPA & change control management•...
Article originally published on GEN The biotechnology industry achieved many firsts this past year, from the first approved drug that can slow the rates of cognitive and functional decline in adults with Alzheimer’s disease, to the first CRISPR-based gene editing...
© 2024 BIOTECHLOGIC, INC | ALL RIGHTS RESERVED